BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34383713)

  • 21. Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis.
    Badalucco S; Di Buduo CA; Campanelli R; Pallotta I; Catarsi P; Rosti V; Kaplan DL; Barosi G; Massa M; Balduini A
    Haematologica; 2013 Apr; 98(4):514-7. PubMed ID: 23403314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril mitigates splenomegaly and myelofibrosis in the Gata1
    Corey SJ; Jha J; McCart EA; Rittase WB; George J; Mattapallil JJ; Mehta H; Ognoon M; Bylicky MA; Summers TA; Day RM
    J Cell Mol Med; 2018 Sep; 22(9):4274-4282. PubMed ID: 29971909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-beta signaling.
    Kim RH; Lieberman MB; Lee R; Shin KH; Mehrazarin S; Oh JE; Park NH; Kang MK
    Exp Cell Res; 2010 Oct; 316(16):2600-8. PubMed ID: 20630502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
    Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
    Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
    J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ALK5/Smad2/3 and MEK1/ERK Signaling in Transforming Growth Factor Beta 1-modulated Growth, Collagen Turnover, and Differentiation of Stem Cells from Apical Papilla of Human Tooth.
    Chang HH; Chang MC; Wu IH; Huang GF; Huang WL; Wang YL; Lee SY; Yeh CY; Guo MK; Chan CP; Hsien HC; Jeng JH
    J Endod; 2015 Aug; 41(8):1272-80. PubMed ID: 26001858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Non-Coding RNA (LncRNA)-ATB Promotes Inflammation, Cell Apoptosis and Senescence in Transforming Growth Factor-β1 (TGF-β1) Induced Human Kidney 2 (HK-2) Cells via TGFβ/SMAD2/3 Signaling Pathway.
    Sun H; Ke C; Zhang L; Tian C; Zhang Z; Wu S
    Med Sci Monit; 2020 May; 26():e922029. PubMed ID: 32447340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells.
    Zhao M; Perry JM; Marshall H; Venkatraman A; Qian P; He XC; Ahamed J; Li L
    Nat Med; 2014 Nov; 20(11):1321-6. PubMed ID: 25326798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis.
    Lecomte S; Devreux J; de Streel G; van Baren N; Havelange V; Schröder D; Vaherto N; Vanhaver C; Vanderaa C; Dupuis N; Pecquet C; Coulie PG; Constantinescu SN; Lucas S
    Blood; 2023 Feb; 141(5):490-502. PubMed ID: 36322928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm.
    Yang Y; Akada H; Nath D; Hutchison RE; Mohi G
    Blood; 2016 Jun; 127(26):3410-23. PubMed ID: 27081096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
    J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche.
    Yao JC; Oetjen KA; Wang T; Xu H; Abou-Ezzi G; Krambs JR; Uttarwar S; Duncavage EJ; Link DC
    J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35439167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells.
    Nie Y; Cui D; Pan Z; Deng J; Huang Q; Wu K
    Mol Vis; 2008 Sep; 14():1631-8. PubMed ID: 18776948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis.
    Varricchio L; Hoffman R
    Front Oncol; 2022; 12():906698. PubMed ID: 35646681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.
    Do TV; Kubba LA; Du H; Sturgis CD; Woodruff TK
    Mol Cancer Res; 2008 May; 6(5):695-705. PubMed ID: 18505915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis.
    Schmitt A; Jouault H; Guichard J; Wendling F; Drouin A; Cramer EM
    Blood; 2000 Aug; 96(4):1342-7. PubMed ID: 10942376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in
    Zingariello M; Verachi P; Gobbo F; Martelli F; Falchi M; Mazzarini M; Valeri M; Sarli G; Marinaccio C; Melo-Cardenas J; Crispino JD; Migliaccio AR
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.